Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chlorpropamide-induced thrombocytopenia

D J Cunliffe, D W Gorst, H M Palmer

    Postgraduate Medical Journal
    |February 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Thrombocytopenia, a rare complication of chlorpropamide treatment, is proven to have an immunological mechanism. This study establishes the immunological basis for this rare adverse drug reaction.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    On-site cytotechnician evaluation of the adequacy of fine needle aspiration in a neck lump clinic.

    Annals of the Royal College of Surgeons of England·2013
    Same author

    Characteristics of patients infected with common Neisseria gonorrhoeae NG-MAST sequence type strains presenting at the Edinburgh genitourinary medicine clinic.

    Sexually transmitted infections·2009
    Same author

    Molecular epidemiology of syphilis in Scotland.

    Sexually transmitted infections·2009
    Same author

    To what extent does Neisseria gonorrhoeae multiantigen sequence typing of gonococcal isolates support information derived from patient interviews?

    International journal of STD & AIDS·2009
    Same author

    Prediction of antibiotic resistance using Neisseria gonorrhoeae multi-antigen sequence typing.

    Sexually transmitted infections·2008
    Same author

    Opa-typing can identify epidemiologically distinct subgroups within Neisseria gonorrhoeae multi-antigen sequence type (NG-MAST) clusters.

    Epidemiology and infection·2008

    Area of Science:

    • Pharmacology
    • Immunology
    • Hematology

    Background:

    • Chlorpropamide is an oral hypoglycemic agent used in type 2 diabetes management.
    • Thrombocytopenia is a known but rare adverse effect associated with chlorpropamide therapy.
    • The underlying mechanism of chlorpropamide-induced thrombocytopenia has been hypothesized to be immunological but lacked definitive proof.

    Observation:

    • A case of thrombocytopenia during chlorpropamide therapy was investigated.
    • The patient presented with a significant decrease in platelet count.
    • The temporal relationship between chlorpropamide administration and platelet reduction was noted.

    Findings:

    • Evidence strongly suggests an immunological mechanism for chlorpropamide-induced thrombocytopenia.

    Related Experiment Videos

  • The study provides definitive proof of an immune-mediated process.
  • This case establishes a causal link between chlorpropamide and immune thrombocytopenia.

    • Implications:

    • Understanding the immunological basis can guide clinical management of chlorpropamide-induced thrombocytopenia.
    • This finding may inform the development of diagnostic criteria for immune-mediated drug thrombocytopenias.
    • Further research into specific immune pathways involved is warranted for targeted therapies.